IMPLICATIONS OF CROSS‐TALK BETWEEN TUMOUR NECROSIS FACTOR AND INSULIN‐LIKE GROWTH FACTOR‐1 SIGNALLING IN SKELETAL MUSCLE
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
SUMMARY: Inflammation, particularly the pro‐inflammatory cytokine tumour necrosis factor (TNF), increases necrosis of skeletal muscle. Depletion of inflammatory cells, such as neutrophils, cromolyn blockade of mast cell degranulation or pharmacological blockade of TNF reduces necrosis of dystrophic myofibres in the mdx mouse model of the lethal childhood disease Duchenne muscular dystrophy (DMD). Insulin‐like growth factor‐1 (IGF‐1) is a very important cytokine for maintenance of skeletal muscle mass and the transgenic overexpression of IGF‐1 within muscle cells reduces necrosis of dystrophic myofibres in mdx mice. Thus, IGF‐1 usually has the opposite effect to TNF. Activation of TNF signalling via the c‐Jun N‐terminal kinase (JNK) can inhibit IGF‐1 signalling by phosphorylation and conformational changes in insulin receptor substrate (IRS)‐1 downstream of the IGF‐1 receptor. Such silencing of IGF‐1 signalling in situations where inflammatory cytokines are elevated has many implications for skeletal muscle in vivo. The basis for these interactions between TNF and IGF‐1 is discussed with specific reference to clinical consequences for myofibre necrosis in DMD and also for the wasting (atrophy) of skeletal muscles that occurs in very old people and in cachexia associated with inflammatory disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Visser, M., Pahor, M., Taaffe, D. R., Goodpaster, B. H., Simonsick, E. M., Newman, A. B., Nevitt, M., & Harris, T. B. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.5.m326 · Cited by 1,294
Inflammatory markers and loss of muscle mass (sarcopenia) and strength
Schaap, L. A., Pluijm, S. M. F., Deeg, D. J. H., & Visser, M. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.049 · Cited by 1,047
Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m101521200 · Cited by 1,010 · cited 1×
“Phosphorylation of the Ser(307) residue leads to dissociation of IRS-1 from the IGF-1 receptor and inhibition of the tyrosine phosphorylation of IRS-1, which is required for the downstream signal transmission from the activated IGF-1 receptor.(61) Use of the JNK inhibitors I-JNK and SP600125 has confirmed the effects…”
BackgroundNguyen, H. X., & Tidball, J. G. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2002.031450 · Cited by 122
Cited by
Aagaard, P., Suetta, C., Caserotti, P., Magnusson, S. P., & Kjær, M. (2010) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/j.1600-0838.2009.01084.x · Cited by 709
Oxidative Stress, Molecular Inflammation and Sarcopenia
Meng, S.-J., & Yu, L.-J. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11041509 · Cited by 637
Role of Inflammation in Muscle Homeostasis and Myogenesis
Costamagna, D., Costelli, P., Sampaolesi, M., & Penna, F. (2015) · Mediators of Inflammation · doi:10.1155/2015/805172 · Cited by 534
The impact of obesity on skeletal muscle strength and structure through adolescence to old age
Tomlinson, D. J., Erskine, R. M., Morse, C. I., Winwood, K., & Onambélé-Pearson, G. (2016) · Biogerontology · doi:10.1007/s10522-015-9626-4 · Cited by 496
Inflammation: Roles in Skeletal Muscle Atrophy
Ji, Y., Li, M., Chang, M., Liu, R., Qiu, J., Wang, K., Deng, C., Shen, Y., Zhu, J., Wang, W., et al. (2022) · Antioxidants · doi:10.3390/antiox11091686 · Cited by 304
Metadata
- Authors
- Grounds, M. D., Radley, H. G., Gebski, B. L., Bogoyevitch, M. A., & Shavlakadze, T.
- Venue
- Clinical and Experimental Pharmacology and Physiology
- Publisher
- Wiley
- Published
- 2008-01-21
- Volume
- 35
- Issue
- 7
- Pages
- 846-851
- ISSN
- 0305-1870 (ISSN-L)
- 1440-1681
- OpenAlex
- W1974512256
- Cited by
- 98
- References
- 4
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: IMPLICATIONS OF CROSS‐TALK BETWEEN TUMOUR NECROSIS FACTOR AND INSULIN‐LIKE GROWTH FACTOR‐1 SIGNALLING IN SKELETAL MUSCLE. https://app.cochat.ai/papers/10.1111/j.1440-1681.2007.04868.x
- The paper
- Grounds, M. D., Radley, H. G., Gebski, B. L., Bogoyevitch, M. A., & Shavlakadze, T. (2008). IMPLICATIONS OF CROSS‐TALK BETWEEN TUMOUR NECROSIS FACTOR AND INSULIN‐LIKE GROWTH FACTOR‐1 SIGNALLING IN SKELETAL MUSCLE. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/j.1440-1681.2007.04868.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.